RecruitingNCT05817617

Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis

Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis: Prospective Multicenter Study of Head-Neck Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)


Sponsor

Centro di Riferimento Oncologico - Aviano

Enrollment

953 participants

Start Date

Aug 8, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about relation between vitamin D levels in subjects with head and neck cancer. The main question it aims to answer are: * variation of vitamin D levels in the study population at different time points * relation between therapy side effects and vitamin D level * relation between disease outcome and vitamin D level Participants will be followed as per clinical practice


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • histologically proven HNSCC (squamous cell carcinomas), all subsites
  • non-metastatic locally advanced stages
  • patients candidate for radical or adjuvant radiotherapy
  • patients candidate for bilateral neck irradiation
  • written informed consent

Exclusion Criteria2

  • distant metastases
  • patients with known disorders of calcium/vitamin D metabolism

Locations(10)

IEO

Milan, Italy

Ospedale Niguarda

Milan, Italy

Ospedale del Mare

Napoli, Italy

Ospedale Mons AR Dimiccoli

Barletta, BAT, Italy

Centro di Riferimento Oncologico - Aviano

Aviano, Pordenone, Italy

Ospedale dell'Angelo

Mestre, Venezia, Italy

Ospedali Riuniti

Ancona, Italy

AORN San Pio

Benevento, Italy

Azienda Ospedaliero Universitaria di Pisa

Pisa, Italy

Policlinico Umberto I

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05817617


Related Trials